CN Patent

CN1627945A — 作为npy拮抗剂的喹啉衍生物

Assigned to F Hoffmann La Roche AG · Expires 2005-06-15 · 21y expired

What this patent protects

通式(I)的化合物及其药物上可接受的盐和酯类可以以药物制剂形式用于治疗或预防关节炎、心血管疾病、糖尿病、肾衰竭、进食障碍和肥胖，其中R 1 、R 2 、R 3 、R 4 和A具有权利要求1中给出的含义。

USPTO Abstract

通式(I)的化合物及其药物上可接受的盐和酯类可以以药物制剂形式用于治疗或预防关节炎、心血管疾病、糖尿病、肾衰竭、进食障碍和肥胖，其中R 1 、R 2 、R 3 、R 4 和A具有权利要求1中给出的含义。

Drugs covered by this patent

paltusotine-hydrochloride (PALTUSOTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN1627945A
Jurisdiction: CN
Classification: —
Expires: 2005-06-15
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.